Access to anti-retroviral drugs, male in Saudi Arabia

Saudi Arabia: Access to anti-retroviral drugs, male was 93.0% in 2024. ◆ Volatile

Latest (2024)
93.0%
Change on year
up 2.2%
World rank
7th
of 141 countries
All-time high
93.0%
in 2024
All-time low
18.0%
in 2000
Years of data
25
2000–2024

Access to anti-retroviral drugs, male in Saudi Arabia, 2000–2024

204060801002000201220242000: 18 %2001: 19 %2002: 21 %2003: 23 %2004: 25 %2005: 28 %2006: 30 %2007: 33 %2008: 36 %2009: 37 %2010: 37 %2011: 38 %2012: 38 %2013: 40 %2014: 45 %2015: 55 %2016: 69 %2017: 73 %2018: 80 %2019: 89 %2020: 90 %2021: 90 %2022: 92 %2023: 91 %2024: 93 %

Source: UNAIDS estimates. Measured in %.

Analysis

In 2024, access to anti-retroviral drugs, male in Saudi Arabia stood at 93.0%. That is the highest value across all 25 years on record.

Compared with earlier readings it is up 2.2% on the previous year and up 106.7% over ten years.

Over the whole period, access to anti-retroviral drugs, male in Saudi Arabia peaked at 93.0% in 2024 and was at its lowest, 18.0%, in 2000.

That places Saudi Arabia 7th out of 141 countries with data for 2024, putting it in the top 10%.

The series is highly variable year to year, so single readings are best treated with caution.

Access to anti-retroviral drugs, male in Saudi Arabia, year by year

Annual values for Access to anti-retroviral drugs, male (%) in Saudi Arabia, 2000 to 2024.
Year % Change
2000 18.0%
2001 19.0% +5.6%
2002 21.0% +10.5%
2003 23.0% +9.5%
2004 25.0% +8.7%
2005 28.0% +12.0%
2006 30.0% +7.1%
2007 33.0% +10.0%
2008 36.0% +9.1%
2009 37.0% +2.8%
2010 37.0% +0.0%
2011 38.0% +2.7%
2012 38.0% +0.0%
2013 40.0% +5.3%
2014 45.0% +12.5%
2015 55.0% +22.2%
2016 69.0% +25.5%
2017 73.0% +5.8%
2018 80.0% +9.6%
2019 89.0% +11.2%
2020 90.0% +1.1%
2021 90.0% +0.0%
2022 92.0% +2.2%
2023 91.0% -1.1%
2024 93.0% +2.2%

Averages by decade

DecadeAverage LowestHighest Years
2000s 27.0% 18.0% 37.0% 10
2010s 56.4% 37.0% 89.0% 10
2020s 91.2% 90.0% 93.0% 5

Countries ranked near Saudi Arabia

  1. 4 Rwanda 95.0% compare
  2. 4 Sweden 95.0% compare
  3. 4 Zambia 95.0% compare
  4. 7 Denmark 93.0% compare
  5. 7 Ethiopia 93.0% compare
  6. 7 United Kingdom of Great Britain and Northern Ireland 93.0% compare

See the full ranking of 160 places →

More gender data for Saudi Arabia

All data for Saudi Arabia →

Frequently asked questions

What is access to anti-retroviral drugs, male in Saudi Arabia?
Access to anti-retroviral drugs, male in Saudi Arabia was 93.0% in 2024, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, male recorded in Saudi Arabia?
The highest recorded value was 93.0% in 2024.
What is the lowest access to anti-retroviral drugs, male recorded in Saudi Arabia?
The lowest recorded value was 18.0% in 2000.
How does Saudi Arabia rank for access to anti-retroviral drugs, male?
Saudi Arabia ranks 7th out of 141 countries with data for 2024.
Is access to anti-retroviral drugs, male rising or falling in Saudi Arabia?
Over the last ten years it is up 106.7%. The long-run trend across the full record is volatile.
Where does this Saudi Arabia data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, male in Saudi Arabia. Statizoid, drawing on UNAIDS estimates. Retrieved 11 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/saudi-arabia/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/saudi-arabia/">Access to anti-retroviral drugs, male in Saudi Arabia</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, male (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,923 data points, 2000–2024
Last refreshed

The percentage of adult males living with HIV who are receiving antiretroviral therapy.